1[1]PIERE L,MARTIN M,NANCY B,et al. A placebo-controlled,doubled-blind,randomized trial of an extract of Ginkgo Biloba for dementia[J]. JAMA,1997,278(16):1327-1332.
2[2]BEAL MF. Aging energy and oxidative stress inneurodegenerative disease [J].Ann Neurol,1995,38:357-366.
3[3]BENZI G, MORRETTI A. Arereactive oxygen speciesinvolved in Alzheimer's disease[J]. Neurobiol Aging,1995,16:661-674.
4[4]MCGEER PL, SCHULZER M, MCGEER EG. Arthritis and anti-inflammatory agents as possible proectivefectors for Alzheimer's disease[J]. Neurology,1996,47:425-432.
5[5]WIRTH S, STEMMELIN J, WILL B, et al. Facilitative effets of EGB761 on olfactory recognitionin young and aged rats[J]. Pharmacol Biochem Behav,2000,65(2):321-326.
6[6]TROVERO F, BROCHET B, TASSIN JP, et al.Ginkgobiloba extract EGB761 reduces the development of amphetamine-induced behavoral sensitization:ieffectson hippocampal type Ⅱ corlicosteroid receptors[J].Brain Res,1999,818 (1):135-
8[8]TADANO T, NAKAGAWASAI O,TAN-NOK, et al. Effectsof ginkgo biloba extract on impairment of learninginduced by cercebral ischemia in mice[J]. AM J Chin Med,1998,26(2):127-132.
9[9]IERRE S, JAMME I, OROY- LEFAIX MT, et al. Ginkgobiloba extract(GB761) protects Na+ -K+ -ATP as activity during cerebral ischemia in mice[J].Neuroreport, 1999,10(1):47-51.
10[10]WEI T,NI Y, HOU J,et al. Hydrogen peroxide-induced oxidative damage and apoptosis incerebellar granule cells:protction by ginkgo biloba extract[J].Pharmacol Res, 2000,41(4):427-433.
二级参考文献3
1Herrmann WM,Stephan K,Geade D,et al. Amulticenter randomized double-blind study on the efficacy nad safety of nicergoline in patients with multi-infarct dementia [J].Dement Geriatr Cogn Disord， 1997， (1):9－ 17
2Benzi Ge， Bernardi M,Manzol， et al. Effect of lysergide and nicergoline on glucose metabolism in vestigated on the dog brain isolated in situ [J].J Pharm Sci ， 1972 ,61(3):348－ 352
